Shock Trauma and Emergency Medicine | Part 2: Commercialization
Trauma, Wound Care, and Emergency Medicine Technology and Impacts in Maryland
Dive into Baltimore’s shock trauma and emergency medicine technology ecosystem in a two-part series. Learn about the technologies that are emerging and the challenges of commercializing them, areas of unmet need, and how local institutions are supporting technology development.
Shock Trauma & Emergency Medicine Commercialization
April 8 | 4 - 5:30 p.m.
The second part of this series will focus on the regional landscape of shock trauma and emergency medicine technology commercialization. Led by Emily English, PhD, former chief executive officer of Gemstone Biotherapeutics, the discussion will illustrate the challenges of moving to the venture capital stage and the financing needed to get there. Learn how Baltimore's diverse life science innovation and technology development ecosystem has strengthened the region and has been leveraged to attract more investment.
Emily English, PhD
Director of Quality, Cartesian Therapeutics, Inc.
CEO and Co-Founder, Longeviti Neuro Solutions
CEO and Co-Founder, ARMR Systems
B. Christie Vu
Program Manager and Contract Officer Representative,
Congressionally Directed Medical Research Programs,
US Army Medical Research and Development Command
CEO and Co-Founder, Sisu Global
Did you miss the conversation?